2. Significance of cooperation: This cooperation will help promote the treatment process in COVID-19 and provide new weapons for the global fight against the COVID-19 epidemic.
3. Cooperation mode: Merck is responsible for drug research and development and production, and Sinopharm Group is responsible for the promotion and sales in China market.
4. Prospects for cooperation: If this COVID-19 oral drug can be successfully developed and marketed, it will have a great impact on the global fight against the COVID-19 epidemic. At the same time, it will also bring huge business opportunities for Merck and Sinopharm Group.
5. Cooperation risk: Due to the uncertainty in COVID-19, the research, development and marketing of this drug may face great risks. At the same time, many companies in China developed vaccines from COVID-19, which also brought competitive pressure to Merck and Sinopharm.
6. Impact of cooperation: This cooperation may change the global pattern of COVID-19 treatment and have a far-reaching impact on the global fight against the COVID-19 epidemic.